Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2015 / Articles / Apr / Mining Social Media
Business & Regulation Business Practice Trends & Forecasts

Mining Social Media

New technology interprets slang and banter to find out what people really think

By Stephanie Vine 04/07/2015 1 min read

Share

Pharma’s forays into the brave new world of social media have not always been successful (tmm.txp.to/0214/brave) – but mining social media for information has attracted a lot of attention. But how exactly do you extract meaningful data from online chatter?

“Most systems for extracting adverse drug reactions (ADRs) follow a dictionary-based approach. The main drawback of these systems is that they fail to recognize terms which are not included in the dictionary,” wrote Isabel Segura-Bedmar, Ricardo Revert and Paloma Martinezin in a recent paper (1). “In addition, the dictionary-based approach is not able to handle the large number of spelling and grammar errors in social media texts.”

To help overcome these issues, the Spanish researchers have developed a system that mines social media and specialized blogs to detect potential ADRs. They have developed a prototype system (2), which uses the framework of Project TrendMiner (a project funded by the European Commission to deliver open-source, real-time methods for mining and summarizing online media) and a linguistic processor based on Daedalus’s commercial MeaningCloud technology. Put simply, the system analyzes comments on social media with natural language processing techniques that can “translate” colloquial descriptions into more structured information. As well as identifying drug names, illnesses and effects, the system registers co-occurrences too; for example, when looking at anti-anxiety drugs, the system can take into account references to the active ingredient, generic name, or commercial brand name, and also pick out references to therapeutic effects and adverse effects.

The researchers envision the technology being used by pharma companies to listen in on what people are saying online about their drugs, or to gather information on suspected ADRs that could be used to supplement existing information sources.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. I. Segura-Bedmar, R. Revert and P. Martinez,“Detecting Drugs And Adverse Events From Spanish Health Social Media Streams”, Proceedings of the 5th International Workshop on Health Text Mining and Information Analysis (2014). I. Segura-Bedma et al., “Exploring Spanish Health Social Media for detecting drug effects”, BMC Medical Informatics and Decision Systems (in press - 2015).

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.